- Oxycodone/naloxone in moderate-to-severe cancer pain: A phase III study in ChinaYu, S.; Xie, G.; Zhang, Q.; Zhang, H.; Li, P.; Lu, P.; Zhang, J.; Feng, J.; Pan, H.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
- Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II TrialLin, Rongbo; Zhu, Jinfeng; Luo, Yushuang; Lv, Xia; Lu, Mingqian; Chen, Haihui; Zou, Huichao; Zhang, Zhichun; Lin, Shaowei; Wu, Milu; Li, Xiaofeng; Zhou, Min; Zhao, Shen; Su, Liyu; Liu, Jiang*; Huang, Cheng*Journal of the National Comprehensive Cancer Network, 2022, 20(9): 1013-+.被引 1
- Multicenter, randomized, double-blind, controlled trial of transcutaneous electrical nerve stimulation for pancreatic cancer related painLihua, He; Keping, Tan; Xianming, Lin; Hui, Yi; Xueliang, Wang; Jiangsong, Zhang; Jietao, Lin; Lizhu, LinMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e23748.
会议论文
Oral opioid vs intravenous patient-controlled analgesia (PCA) with hydromorphone bolus-only or continuous infusion to maintain analgesia for severe cancer pain: A randomized phase III trial
11阅读
